Lataa...
Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer
Despite the recent advances in the biological understanding of breast cancer (BC), chemotherapy still represents a key component in the armamentarium for this disease. Different agents are available as mono-chemotherapy options in patients with locally advanced or metastatic BC (MBC) who progress af...
Tallennettuna:
| Julkaisussa: | J Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7719522/ https://ncbi.nlm.nih.gov/pubmed/33312203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9645294 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|